We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

DOO:NASDAQBRP Inc. Analysis

Data as of 2026-06-12 - not real-time

$59.12

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

BRP Inc. (DOO) is trading at $59.12, just above its 20‑day SMA ($58.04) but below the 50‑day SMA ($60.09) and well under the 200‑day SMA ($67.00), indicating short‑term momentum but a longer‑term bearish bias. The MACD histogram is positive (0.29) and the signal line is bullish, while the RSI sits near the midpoint at 50.8, suggesting limited overbought pressure. Volatility remains high at 36% over the past 30 days and beta is modestly above 1, reflecting sensitivity to market swings. Valuation metrics show a forward PE of 17.3 and a price‑to‑book of 8.68, yet a discounted cash‑flow model implies a fair value of $407, translating to an implied upside of roughly 19% and supporting an undervalued label.
Fundamentally, the company posted 29.5% revenue growth, a strong ROE of 52%, and solid operating cash flow of $1.38B, but carries a very high debt‑to‑equity ratio (over 400) and a net‑debt burden that tempers the upside. The recent earnings beat and raised outlook, despite U.S. tariff pressures, spurred a nearly 9% share rally, underscoring market confidence in the brand’s resilience. Dividend sustainability looks sound with a 21% payout ratio and a modest 1.22% yield. Overall, the blend of growth drivers, attractive upside potential, and manageable dividend risk positions DOO as a compelling buy for investors willing to navigate its cyclical and leverage‑related risks.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Positive MACD crossover with neutral RSI
  • Recent earnings beat and 9% price rally
  • Support level at $52.58 and increasing volume

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Strong revenue growth (29.5%) and high ROE (52%)
  • DCF implied upside of ~19% toward $70 target
  • Sustained dividend with low payout ratio

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • High debt‑to‑equity ratio increasing financial risk
  • Cyclical consumer exposure and tariff uncertainty
  • Robust brand portfolio and diversified geographic footprint

Key Metrics & Analysis

Financial Health

Revenue Growth29.50%
Profit Margin3.01%
P/E Ratio19.7
ROE52.33%
ROA7.19%
Debt/Equity415.87
P/B Ratio8.7
Op. Cash Flow$1.4B
Free Cash Flow$899.2M

Technical Analysis

TrendBearish
RSI50.8
Support$52.58
Resistance$63.86
MA 20$58.04
MA 50$60.09
MA 200$67.00
MACDBullish
VolumeIncreasing
Fear & Greed Index87.05

Valuation

Fair Value$407.05
Target Price$70.24
Upside/Downside18.82%
GradeUndervalued
TypeGrowth
Dividend Yield1.22%

Risk Assessment

Beta1.12
Volatility36.03%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.